120 related articles for article (PubMed ID: 25182004)
1. BRMS1 regulates apoptosis in non-small cell lung cancer cells.
You J; He X; Ding H; Zhang T
Cell Biochem Biophys; 2015 Jan; 71(1):465-72. PubMed ID: 25182004
[TBL] [Abstract][Full Text] [Related]
2. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
Liu Y; Mayo MW; Xiao A; Hall EH; Amin EB; Kadota K; Adusumilli PS; Jones DR
Mol Cell Biol; 2015 Jan; 35(1):303-17. PubMed ID: 25368381
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression.
Wu Y; Jiang W; Wang Y; Wu J; Saiyin H; Qiao X; Mei X; Guo B; Fang X; Zhang L; Lou H; Wu C; Qiao S
PLoS One; 2012; 7(8):e42976. PubMed ID: 22927944
[TBL] [Abstract][Full Text] [Related]
4. HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.
Gu S; Zhang R; Gu J; Li X; Lv L; Jiang J; Xu Z; Wang S; Shi C; Wang DP; Wu C
Oncol Rep; 2017 Jan; 37(1):474-482. PubMed ID: 27878283
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.
Smith PW; Liu Y; Siefert SA; Moskaluk CA; Petroni GR; Jones DR
Cancer Lett; 2009 Apr; 276(2):196-203. PubMed ID: 19111386
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer metastasis suppressor 1 (BRMS1) suppresses prostate cancer progression by inducing apoptosis and regulating invasion.
Zhang HM; Qiao QD; Xie HF; Wei JX
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):68-75. PubMed ID: 28121354
[TBL] [Abstract][Full Text] [Related]
7. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
Haura EB; Zheng Z; Song L; Cantor A; Bepler G
Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
[TBL] [Abstract][Full Text] [Related]
8. IL-17 promoted metastasis of non-small-cell lung cancer cells.
Li Q; Han Y; Fei G; Guo Z; Ren T; Liu Z
Immunol Lett; 2012 Dec; 148(2):144-50. PubMed ID: 23089548
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
[TBL] [Abstract][Full Text] [Related]
10. Effect of BRMS1 on tumorigenicity and metastasis of human rectal cancer.
Zhang Y; Guan J; Sun Y; Chai J; Zou T; Gong W; Zhu Z; Liu X; Hou Q; Song X
Cell Biochem Biophys; 2014 Sep; 70(1):505-9. PubMed ID: 24748145
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1.
Hedley BD; Welch DR; Allan AL; Al-Katib W; Dales DW; Postenka CO; Casey G; Macdonald IC; Chambers AF
Int J Cancer; 2008 Aug; 123(3):526-34. PubMed ID: 18470911
[TBL] [Abstract][Full Text] [Related]
12. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients.
Li X; Yu Z; Li Y; Liu S; Gao C; Hou X; Yao R; Cui L
Int J Oncol; 2015 Feb; 46(2):798-808. PubMed ID: 25531908
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.
Yang J; Zhang B; Lin Y; Yang Y; Liu X; Lu F
Cancer Lett; 2008 Sep; 269(1):46-56. PubMed ID: 18502034
[TBL] [Abstract][Full Text] [Related]
15. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
16. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.
Shi X; Sun M; Liu H; Yao Y; Kong R; Chen F; Song Y
Mol Carcinog; 2015 Jun; 54 Suppl 1():E1-E12. PubMed ID: 24357161
[TBL] [Abstract][Full Text] [Related]
17. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q
Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459
[TBL] [Abstract][Full Text] [Related]
18. BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.
Nagji AS; Liu Y; Stelow EB; Stukenborg GJ; Jones DR
J Pathol; 2010 Jun; 221(2):229-37. PubMed ID: 20455258
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
20. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
